colestilan

DRUG3 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Chronic Kidney DiseaseDialysisHyperphosphatemiaNot on DialysisPaediatric

Phase 1

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

CompletedNCT01976572

Tanabe Pharma CorporationChronic Kidney Disease, Hyperphosphatemia

Start: 2013-10-31End: 2014-01-31Updated: 2026-01-07

Phase 3

Long-term Extension Study of MCI-196

TerminatedNCT01814917

Tanabe Pharma CorporationChronic Kidney Disease, Dialysis, Hyperphosphatemia +1

Start: 2013-08-31End: 2014-12-31Updated: 2015-05-27

Safety and Tolerability Study of MCI-196

TerminatedNCT01818687

Tanabe Pharma CorporationChronic Kidney Disease, Hyperphosphatemia, Not on Dialysis +1

Start: 2013-08-31End: 2014-12-31Updated: 2015-05-27